Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS

AGIO Stock Annual Income Statement. Download in Excel

Agios Pharmaceuticals Inc. logo

Agios Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

29.26
 
USD
  
0.89
  
(3.14%)
Previous close: 28.37  Open: 28.3  Bid: 24.85  Ask: 34.0
52 week range    
23.42   
   62.58
Mkt Cap: 1,604 M  Avg Vol (90 Days): 669,532
Last updated: Friday 25th April 2025

Stock Rankings

54
MarketXLS Rank
80
Value
27
Technical
57
Quality
How are these ranks calculated?
Search for a stock

Financials

AGIO Income Statement

Annual
Dec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22Dec-23Dec-24
Basic EPS from continuing operations-6.8620.65-8.46-12.6611.86
Basic EPS total-6.8653.1-8.46-6.3311.86
Basic weighted shares outstanding37 M39 M47 M57 M60 M69 M60 M55 M56 M57 M
BasicDiscontinuousOperations32.45
Cost of sales-135000.0-70000.0-1 M1 M-3 M2 M3 M4 M
Depreciation-3 M-6 M-6 M-7 M8 M9 M9 M8 M7 M6 M
DepreciationAndAmortization-3 M-6 M-6 M-7 M8 M9 M9 M8 M7 M6 M
Diluted EPS total-3.15-5.07-6.75-6.03-6.86-4.7453.1-8.46-6.3311.64
Diluted normalized net income/share20.65-8.46-12.6611.64
Diluted weighted shares outstanding37 M39 M47 M57 M60 M86 M60 M55 M56 M58 M
DilutedDiscontinuousOperations32.45
GainOnSaleOfBusiness7 M200 M
GainOnSaleOfSecurity-261000.0
GeneralAndAdministrativeExpense36 M51 M-6 M-11 M132 M115 M121 M122 M120 M157 M
Gross operating profit59 M70 M43 M93 M117 M200 M500000.013 M24 M32 M
Income before tax-118 M-198 M-315 M-346 M-411 M-329 M-357 M-232 M-352 M718 M
Income taxes44 M
Interest income968000.03 M6 M16 M15 M7 M836000.013 M33 M48 M
InterestExpenseNonOperating18 M
MiscOtherSpecialCharges38 M32 M62 M21 M17 M6 M6 M
Net income from total operations-118 M-198 M-315 M-346 M-411 M-327 M1,605 M-232 M-352 M674 M
NetIncomeCommonStockholders-118 M-198 M-315 M-346 M-411 M-327 M1,605 M-232 M-352 M674 M
NetIncomeContinuousOperations-118 M-198 M-315 M-346 M-411 M-327 M1,605 M-232 M-352 M674 M
NetIncomeDiscontinuousOperations2 M1,961 M
NetIncomeFromOtherGainsLosses-18 M
NetNonOperatingInterestIncomeExpense968000.03 M6 M16 M15 M7 M836000.013 M33 M48 M
Normalized income511 M
Operating income-119 M-201 M-321 M-362 M-426 M-336 M-378 M-389 M-391 M-426 M
Operating income before depreciation (EBITDA)-114 M-192 M-308 M-343 M-398 M-326 M-369 M-380 M-335 M735 M
OperatingExpense-178 M-271 M-364 M455 M543 M336 M378 M402 M415 M458 M
Other income net261000.0-38 M-32 M-62 M-21 M144 M-6 M-206 M
OtherGainLossFromDispositionOfDiscontinuedOperations2 M1,961 M
OtherGandA36 M51 M-6 M-11 M132 M115 M121 M122 M120 M157 M
OtherOperatingExpenses-364 M-457 M-3 M-4 M-3 M-2 M-2 M-3 M
RentAndLandingFees36 M51 M-6 M-11 M
Research & development expense142 M220 M293 M341 M411 M221 M257 M280 M296 M301 M
ResearchExpense142 M220 M293 M341 M411 M221 M257 M280 M296 M301 M
SalariesAndWages-32 M-42 M-48 M-73 M-75 M
Selling Gen & administrative expense36 M51 M71 M114 M132 M115 M121 M122 M120 M157 M
SellingAndMarketingExpense71 M114 M149 M
SellingExpense71 M114 M149 M
Total Income available for interest expense (EBIT)-118 M-198 M-315 M-346 M-411 M-336 M-378 M-389 M-352 M718 M
Total common shares outstanding38 M42 M57 M58 M69 M70 M55 M55 M56 M57 M
Total net income-118 M-198 M-315 M-346 M-411 M-327 M1,605 M-232 M-352 M674 M
Total ordinary shares57 M57 M57 M57 M57 M57 M57 M57 M57 M57 M
Total revenues59 M70 M43 M94 M118 M121 M500000.014 M27 M36 M
TotalExpenses-178 M-271 M-364 M454 M544 M514 M378 M403 M418 M462 M
TotalRevenue59 M70 M43 M94 M118 M203 M500000.014 M27 M36 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement "your own" investment strategies in Excel with thousands of MarketXLS functions and templates.
MarketXLS provides all the tools I need for in-depth stock analysis. It's user-friendly and constantly improving. A must-have for serious investors.

John D.

Financial Analyst

I have been using MarketXLS for the last 6+ years and they really enhanced the product every year and now in the journey of bringing in AI...

Kirubakaran K.

Investment Professional

MarketXLS is a powerful tool for financial modeling. It integrates seamlessly with Excel and provides real-time data.

David L.

Financial Analyst

I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel.

Lloyd L.

Professional Trader